New research clears the way to healing lung diseases
Pulmonary fibrosis is a deadly disease in which scar tissue grows in the lungs, making breathing more difficult. Approximately 2,170 Australians are diagnosed annually with idiopathic pulmonary…
Read the full articleYou might also wanna read

Discovery of lung protein offers hope for pulmonary fibrosis
Pulmonary fibrosis is a deadly disease where scar tissue grows in the lungs, making breathing more difficult. Approximately 2,170 Australian

Large international study validates genetic risk score for diagnosing and predicting pulmonary fibrosis outcomes
ROCHESTER, Minn. — Researchers have validated a genetic scoring tool that may help physicians diagnose idiopathic pulmonary fibrosis and ide
A Prospective, Multi-Center Registry Study of Progressive Pulmonary Fibrosis (PPF) in China (PROFINA)
Conditions : Progressive Pulmonary Fibrosis Sponsors : Zuojun Xu; Boehringer Ingelheim Recruiting

Insilico Medicine advances AI drug for IPF to Phase III trials
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF).
Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography
Conditions : Lung Disease, Interstitial; Idiopathic Pulmonary Fibrosis (IPF); Incidental Findings; Interstitial Lung Disease (ILD); Chest X-
Australia's Lung Cancer Screening Program Sees High Uptake, Detects 230+ Cancers in First Year
The first year of Australia’s lung cancer screening program appears to be a success, with high uptake among its target population of heavy s

Comments
Sign in to join the conversation.
No comments yet. Be the first.